Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides
about
Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimersInteraction of the v-Rel oncoprotein with cellular transcription factor Sp1Differential contributions of ApoE4 and female sex to BACE1 activity and expression mediate Aβ deposition and learning and memory in mouse models of Alzheimer's diseaseFunctional analysis of newly discovered growth control genes: experimental approaches.Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotideThe future of antisense therapy: combination with anticancer treatments.Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin.Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides.Sequence context of antisense RelA/NF-kappa B phosphorothioates determines specificity.Binding features of BCL2-targeted oligodeoxynucleotides with K562 cells.Targeted antisense modulation of inflammatory cytokine receptors.Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide.Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors.Antisense oligodeoxynucleotides as clinical therapeutic agents.Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.Antisense strategy: biological utility and prospects in the treatment of hematological malignancies.Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta.
P2860
Q24547040-3CE40519-8997-449D-801F-605A51F53544Q24645607-9B6C2E1A-E1A5-407C-8365-425A5783DB3BQ27323892-4B27C712-06A0-44E5-94AE-E1B9E99EFF55Q33716358-8DB173F6-D7DF-4DAF-A324-CC8A818532AAQ33978043-A83CC07C-6D70-4518-9F1A-921451C2BBA8Q35551139-6A31B0FB-6F13-450E-B367-35B2B4B49E69Q36437931-E3EF95F0-149B-4C6F-88B7-EE659E1C16FBQ38291471-636E7492-413F-4ED8-BFCE-FF08AD160592Q38296643-7FDE5D50-939A-4B7C-8BCD-4676F949B2E5Q38333934-D2F04019-277D-44CB-BE5A-3E88682425CEQ38344362-F3C83C94-BC4B-4A99-82C9-578E4968D5BDQ38361683-85EF2393-970A-4DA8-A531-967F8AB16033Q39720488-B78345B6-76C0-4372-9FBD-8879C55CBF05Q40770171-EBA9471A-2286-4052-93A9-AB67DB2886BDQ40968139-BECFF30F-C4CB-428B-95B3-BB056DDEAE1CQ41014533-E0252A0F-6E9F-4F36-9FBA-AB430263D3D3Q41141202-51F98834-B757-4EC2-8A98-3FF94E1A12DBQ41475501-A0756A3E-CF6A-4131-AC25-07E041D64C09Q42070047-46CA80EC-7F12-4B66-9282-32625A6AAEB2
P2860
Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Sequence-independent induction ...... othioate oligodeoxynucleotides
@ast
Sequence-independent induction ...... othioate oligodeoxynucleotides
@en
type
label
Sequence-independent induction ...... othioate oligodeoxynucleotides
@ast
Sequence-independent induction ...... othioate oligodeoxynucleotides
@en
prefLabel
Sequence-independent induction ...... othioate oligodeoxynucleotides
@ast
Sequence-independent induction ...... othioate oligodeoxynucleotides
@en
P2093
P2860
P356
P1476
Sequence-independent induction ...... othioate oligodeoxynucleotides
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.13.5957
P407
P577
1994-06-01T00:00:00Z